Source: PR Newswire

Press Release: Mymetics : Mymetics to Present New Preclinical Data on Thermostable and Cold-Chain Independent Virosome based Vaccines

EPALINGES, Switzerland, Sept. 13, 2017 /PRNewswire/ -- Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases, announced today that they will present new preclinical data. The new data...

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Mymetics yet.

Missing a competitor? Contribute!

Annual Revenue
Employees
Ronald Kempers's photo - President & CEO of Mymetics

President & CEO

Ronald Kempers

CEO Approval Rating

68/100



Mymetics's headquarters is in Epalinges, Other. Mymetics has a revenue of $691.1K, and 1 employees. Mymetics has 4 followers on Owler.